Select Bibliography

Filter by any of these (after searching):

Zaanan, Aziz

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 5 items

Prognostic Variables in Low and High Risk Stage III Colon Cancers Treated in Two Adjuvant Chemotherapy Trials

Sinicrope, Frank A. , Chakrabarti, Sakti , Laurent-Puig, Pierre ... - - Eur J Cancer - 2021

Manuscript - Secondary - Primary - Correl Sci NOS - NCCTG-N0147

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy

Zaanan, Aziz , Shi, Qian , Taieb, Julien , Alberts, Steven R. ... - - JAMA Oncol - 2018

Manuscript - Secondary - Primary - Correl Sci NOS - NCCTG-N0147

Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials

Zaanan, Aziz , Shi, Qian , Taieb, Julien , Alberts, Steven R. ... - ASCO - J Clin Oncol - 2019

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147

Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients treated with adjuvant FOLFOX + cetuximab in the PETACC8 and N0147 adjuvant trials.

Zaanan, Aziz , Shi, Qian , Taieb, Julien , Alberts, Steven R. ... - ASCO - J Clin Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147

Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.

Zaanan, Aziz , Shi, Qian , Taieb, Julien , Alberts, Steven R ... - - JCO Precis Oncol - 2020

Manuscript - Secondary - Primary - Correl Sci NOS - NCCTG-N0147